Natural D-glucose as a biodegradable MRI relaxation agent.

Mark McIntosh,'s picture
PubMed URL:
van Zijl PC
Author List: 
Yadav NN
Xu J
Bar-Shir A
Qin Q
Chan KW
Grgac K
Li W
McMahon MT
van Zijl PC
Magn Reson Med
PubMed ID: 
Demonstrate applicability of natural D-glucose as a T2 MRI contrast agent.D-glucose solutions were prepared at multiple concentrations and variable pH. The relaxation rate (R2  = 1/T2 ) was measured at 3, 7, and 11.7 T. Additional experiments were performed on blood at 11.7 T. Also, a mouse was infused with D-glucose (3.0 mmol/kg) and dynamic T2 weighted images of the abdomen acquired.The transverse relaxation rate depended strongly on glucose concentration and solution pH. A maximum change in R2 was observed around physiological pH (pH 6.8-7.8). The transverse relaxivities at 22°C (pH 7.3) were 0.021, 0.060, and 0.077 s(-1) mM(-1) at 3.0, 7.0, and 11.7 T, respectively. These values showed good agreement with expected values from the Swift-Connick equation. There was no significant dependence on glucose concentration or pH for T1 and the diffusion coefficient for these solutions. The transverse relaxivity in blood at 11.7 T was 0.09 s(-1) mM(-1) . The dynamic in vivo experiment showed a 10% drop in signal intensity after glucose infusion followed by recovery of the signal intensity after about 50-100 s.Glucose can be used as a T2 contrast agent for MRI at concentrations that are already approved for human use.
Published Date: 
September, 2014

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.

Learn more.

Appointments & Referrals



Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.


Resource Finder


A free resource that provides access to information and support for individuals and families living with developmental disabilities.